Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04245722
Title FT596 as a Monotherapy and in Combination With Anti-CD20 Monoclonal Antibodies
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Fate Therapeutics
Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.